Veteran corporate executive and investor focused on growth-stage companies across technology, healthcare and industrials, with operational leadership and board experience supporting scaling, M&A and capital raises. Bill Parsons leverages a background in CEO and operating roles to advise private equity and venture capital investors on value creation, go-to-market strategy and post-acquisition integration.
Veteran corporate executive and investor focused on growth-stage companies across technology, healthcare and industrials, with operational leadership and board experience supporting scaling, M&A and capital raises. Bill Parsons leverages a background in CEO and operating roles to advise private equity and venture capital investors on value creation, go-to-market strategy and post-acquisition integration.
Operates as an operationally-focused growth investor targeting technology, healthcare and industrial companies where CEO-level experience accelerates scale. Prefers growth equity and control/minority investments that pair capital with hands-on board engagement to drive go-to-market expansion, M&A-led consolidation and post‑acquisition integration. Underwrites deals on revenue traction, unit economics and scalable operations, emphasizes multi-year value creation through commercial scaling, cost structure optimization and disciplined follow-on capital allocation.
Operates as an operationally-focused growth investor targeting technology, healthcare and industrial companies where CEO-level experience accelerates scale. Prefers growth equity and control/minority investments that pair capital with hands-on board engagement to drive go-to-market expansion, M&A-led consolidation and post‑acquisition integration. Underwrites deals on revenue traction, unit economics and scalable operations, emphasizes multi-year value creation through commercial scaling, cost structure optimization and disciplined follow-on capital allocation.
| Trades 881 | Longs Won 603/881 68% | Profit Factor 13.09 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $756,425.35 |
| Average Win $122,636.01 | Best Trade (Oct 15) $18.28M | Sharpe Ratio -11.42 |
| Average Loss -$20,324.92 | Worst Trade (Oct 15) -$203,893.11 | Z-Score 9.67 (100%) |
| Commissions $0 | Avg. Trade Length 11m 2w 3d | Expectancy $77,524.61 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.09% |
| Consecutive Losing Trades | 12,195 | 10,976 | 9,756 | 8,537 | 7,317 | 6,098 | 4,878 | 3,659 | 2,439 | 1,220 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 21,560 | $4.37M | $7.43M | - | $3.06M | 69.99% | +0.81% |
ABBV AbbVie Inc. | 1,199 | $268,614.16 | $341,277.36 | - | $72,663.2 | 27.05% | +0.436% |
ABNB Airbnb, Inc. | 2,982 | $421,269.69 | $519,590.84 | - | $98,321.15 | 23.34% | -0.022% |
ABT Abbott Laboratories | 2,140 | $194,183.6 | $223,747.7 | - | $29,564.1 | 15.22% | -0.119% |
AME Ametek Inc. | 797 | $202,215 | $198,325.48 | - | -$3,889.52 | -1.92% | +0.129% |
AMGN Amgen Inc. | 579 | $203,721 | $251,726.04 | - | $48,005.04 | 23.56% | +0.168% |
AMLP Alerian MLP ETF | 15,136 | $663,820.99 | $790,250.56 | - | $126,429.57 | 19.05% | +0.578% |
AMP Ameriprise Financial, Inc. | 404 | $185,339.05 | $202,638.32 | - | $17,299.27 | 9.33% | -0.199% |
AMT American Tower Corporation | 1,864 | $307,101 | $343,479.28 | - | $36,378.28 | 11.85% | +1.605% |
AMZN Amazon.com Inc | 9,353 | $1.65M | $2.37M | - | $717,872.95 | 43.5% | -0.62% |
ANET Arista Networks, Inc. | 1,139 | $192,046.89 | $204,963.05 | - | $12,916.16 | 6.73% | -3.034% |
AOA iShares Core Aggressive Allocation ETF | 14,459 | $1.06M | $1.41M | - | $342,411.58 | 32.21% | -0.251% |
AUR Aurora Innovation, Inc. | 85,000 | $561,750.5 | $438,175 | - | -$123,575.5 | -22% | -4.537% |
AVDE Avantis International Equity ETF | 4,528 | $311,143.28 | $408,765.2 | - | $97,621.92 | 31.38% | +0.428% |
AVEM Avantis Emerging Markets Equity ETF | 3,210 | $309,667.16 | $286,717.2 | - | -$22,949.96 | -7.41% | -1.195% |
AVGO Broadcom Inc. | 1,888 | $597,509.56 | $631,536 | - | $34,026.44 | 5.69% | -2.855% |
AVLV Avantis U.S. Large Cap Value ETF | 5,776 | $393,722.77 | $539,420.64 | - | $145,697.87 | 37.01% | +0.011% |
AVUV Avantis U.S. Small Cap Value ETF | 2,330 | $226,911.35 | $280,869.85 | - | $53,958.5 | 23.78% | +0.087% |
BAC Bank of America Corporation | 5,243 | $298,459.92 | $273,160.3 | - | -$25,299.62 | -8.48% | +0.774% |
BIIB Biogen Inc. | 975 | $200,840.16 | $229,476 | - | $28,635.84 | 14.26% | +0.004% |